|Page (1) of 1 - 05/27/13||email article||print page|
Project Oncology CME Series Launches on ReachMD, Offering Learners a Wide Array of Certified Oncology Activities Across an Integrated Platform(May 27, 2013)
Fort Washington, PA (PRWEB) May 27, 2013
ReachMD, an award-winning producer and distributor of advanced healthcare information and education for medical professionals, announced today the launch of a new CME series designed for oncology professionals across the spectrum of cancer disciplines. Project Oncology features CME activities such as:
- Therapeutic Approaches in Maintenance for Relapsed and Refractory Multiple Myeloma
- Late-Breaking Clinical Trials from the Society for Melanoma Research
Based on feedback from our ReachMD learners, Project Oncology allows us to deliver what we know they really appreciate when selecting education -- an integrated platform of on air, online, and mobile oncology education, said Matt Birnholz, MD, Medical Director of ReachMD. We think the topics and featured oncology experts will enhance that learning.
Project Oncology launches with five CME activities certified by educational providers, including the National Comprehensive Cancer Network (NCCN) and The Omnia-Prova Education Collaborative (TOPEC). Current activities focus on melanoma and multiple myeloma. Future activities are slated for breast cancer, colon cancer, lung cancer, and other areas of interest to oncology professionals nationwide.
ReachMD is the first and only national radio channel for healthcare professionals that broadcasts information and education 24/7 on XM Satellite Channel 245, streams simulcasts on ReachMD.com, offers on-demand podcasts online and through the ReachMD MedicalRadio app, and communicates weekly with subscribers through e-programming guides. ReachMD leverages its proprietary broadcast technologies to deliver compelling content geared to help time-constrained healthcare professionals stay abreast of research, expert commentary, treatment protocols, conference coverage, and CME requirements. More information is available at http://www.ReachMD.com.
Read the full story at http://www.prweb.com/releases/Project/Oncology/prweb10761095.htm.